Mykundex (Nystatin)

Nystatin, the active ingredient in Mykundex, is a polyene antifungal presented as an oral formulation for oral use. It treats oral and gastrointestinal candidiasis in patients with fungal overgrowth. GNH USA supplies Mykundex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mykundex is a polyene antifungal used to treat fungal infections of the oral cavity and gastrointestinal tract. - Oral candidiasis (thrush): reduces fungal load and resolves symptoms of mouth infection. - Gastrointestinal candidiasis: eradicates Candida overgrowth in the digestive system. - Esophageal candidiasis: alleviates fungal infection of the esophagus when administered as an oral suspension.

Nystatin may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset after oral administration. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools during treatment. - Abdominal cramps: transient discomfort in the abdomen. - Altered taste: temporary metallic or bitter sensation. - Mild skin rash: localized erythema at the site of contact.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hepatotoxicity: uncommon liver enzyme elevation. - Severe hypersensitivity: swelling of face, lips, or tongue.

Before using Mykundex, consider the following safety measures. - Renal impairment: monitor kidney function as unchanged drug is excreted renally. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Breastfeeding: evaluate risk versus benefit because excretion in milk is unknown. - Concomitant antibiotics: monitor for altered gut flora that may affect efficacy. - Known hypersensitivity: avoid if the patient has a documented allergy to polyene antifungals. - Store below 25°C: keep in the original container, protect from moisture and light.

Nystatin can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Amphotericin B: concurrent use may increase nephrotoxicity risk. - Systemic azoles (e.g., fluconazole): may reduce nystatin's local efficacy. - Live vaccines: theoretical risk of reduced vaccine effectiveness.

Moderate Interactions (Monitor Closely): - Antacids: altered gastric pH may affect drug dissolution. - Broad‑spectrum antibiotics: may predispose to fungal overgrowth, requiring clinical observation.